Original Investigation
Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial

https://doi.org/10.1016/j.jacc.2020.10.047Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

The association of age with the outcomes of bilateral internal thoracic arteries (BITAs) versus single internal thoracic arteries (SITAs) for coronary bypass grafting (CABG) remains to be determined.

Objectives

The purpose of this study was to evaluate the association between age and BITA versus SITA outcomes in the Arterial Revascularization Trial.

Methods

The primary endpoints were all-cause mortality and a composite of major adverse events, including all-cause mortality, myocardial infarction, or stroke. Secondary endpoints were bleeding complications and sternal wound complications up to 6 months after surgery. Multivariable fractional polynomials analysis and log-rank tests were used.

Results

Age did not affect any of the explored outcomes in the overall BITA versus SITA comparison in the intention-to-treat analysis and in the analysis based on the number of arterial grafts received. However, when the intention-to-treat analysis was restricted to the populations of patients between age 50 and 70 years, younger patients in the BITA arm had a significantly lower incidence of major adverse events (p = 0.03).

Conclusions

Our results suggest that BITA may improve long-term outcome in younger patients, although more randomized data are needed to confirm this hypothesis.

Key Words

bilateral internal thoracic arteries
CABG
single internal thoracic artery

Abbreviations and Acronyms

BITA
bilateral internal thoracic artery
CABG
coronary artery bypass grafting
HR
hazard ratio
MFP
multivariable fractional polynomials
RCT
randomized controlled trial
SITA
single internal thoracic artery

Cited by (0)

Listen to this manuscript's audio summary by Editor-in-Chief Dr. Valentin Fuster on JACC.org.

Joanna Chikwe, MD, served as Guest Associate Editor for this paper. Athena Poppas, MD, served as Guest Editor-in-Chief for this paper.

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.